Synthetic biology is defined as novel area of research which is the amalgamation of multiple disciplines like molecular biology, biotechnology, genetic engineering, biophysics, and others. It involves design and construction of new biological systems from standardized genetic components coupled with essential redesign of existing life for new purposes.
Increase in investment and funding from key companies in synthetic biology expected to boost the global synthetic biology industry growth during this forecast period. For instance, in January 2018, as per the SynBioBeta data around 50 companies including private as well as public companies raised over US$ 1.7 bn fir the development of innovative synthetic biology technologies. Also, increase in number of synthetic biology research entitles and declining cost of DNA synthesizing & sequencing are some driving factors expected to propel the global synthetic biology market growth. Moreover, increase in, demand for bio-fuels, and growing awareness regarding this technologies in emerging economies will support the market growth during this forecast timeline. In addition to that, increase in research and development activities for synthetic drugs and vaccines will drive the market growth in near future.
Increase in bio-safety, ethical, as well as bio-security concerns is major restraint which is expected to hinder the global synthetic biology market growth. Also, standardization of biological parts is the challenging factor which is expected to limit the global synthetic biology market growth over the forecast period.
Global Synthetic Biology Market is segmented into product such as Synthetic DNA, Synthetic Genes, Synthetic Oligos, Software Tools, Chassis Organisms, Synthetic Clones, and synthetic Cells, by technology such as Bioinformatics, Microfluidics, and Genetic engineering. Further, market is segmented into application such as Pharmaceuticals & Diagnostics, Chemicals, Biofuels, Bioplatics, and Others.
Also, Global Synthetic Biology Market is segmented on the basis of five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Thermo Fisher Scientific, Inc., Codexis, Inc., Synthetic Genomics, Inc, Twist Bioscience, Genscript Biotech Corporation, Intrexon Corporation, Amyris, Inc., Ginkgo Bioworks, Novozymes A/S, Agilent Technologies, Inc,, and Merck Kgaa
Market Drivers
Increase in investment and funding from key companies in synthetic biology expected to boost the global synthetic biology industry growth during this forecast period. For instance, in January 2018, as per the SynBioBeta data around 50 companies including private as well as public companies raised over US$ 1.7 bn fir the development of innovative synthetic biology technologies. Also, increase in number of synthetic biology research entitles and declining cost of DNA synthesizing & sequencing are some driving factors expected to propel the global synthetic biology market growth. Moreover, increase in, demand for bio-fuels, and growing awareness regarding this technologies in emerging economies will support the market growth during this forecast timeline. In addition to that, increase in research and development activities for synthetic drugs and vaccines will drive the market growth in near future.
Market Restraints
Increase in bio-safety, ethical, as well as bio-security concerns is major restraint which is expected to hinder the global synthetic biology market growth. Also, standardization of biological parts is the challenging factor which is expected to limit the global synthetic biology market growth over the forecast period.
Market segmentation
Global Synthetic Biology Market is segmented into product such as Synthetic DNA, Synthetic Genes, Synthetic Oligos, Software Tools, Chassis Organisms, Synthetic Clones, and synthetic Cells, by technology such as Bioinformatics, Microfluidics, and Genetic engineering. Further, market is segmented into application such as Pharmaceuticals & Diagnostics, Chemicals, Biofuels, Bioplatics, and Others.
Also, Global Synthetic Biology Market is segmented on the basis of five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market key players
Various key players are discussed in this report such as Thermo Fisher Scientific, Inc., Codexis, Inc., Synthetic Genomics, Inc, Twist Bioscience, Genscript Biotech Corporation, Intrexon Corporation, Amyris, Inc., Ginkgo Bioworks, Novozymes A/S, Agilent Technologies, Inc,, and Merck Kgaa
Market Taxonomy
By Product
- Synthetic DNA
- Synthetic Genes
- Synthetic Oligos
- Software Tools
- Chassis Organisms
- Synthetic Clones
- Synthetic Cells
By Technology
- Bioinformatics
- Microfluidics
- Genetic engineering
By Application
- Pharmaceuticals & Diagnostics
- Chemicals
- Biofuels
- Bioplatics
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Synthetic Biology Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
Table of Contents
1 Introduction
2 Research Methodology
4 Global Synthetic Biology Market Outlook
5 Global Synthetic Biology Market, By Product
6 Global Synthetic Biology Market, By Technology
7 Global Synthetic Biology Market, By Application
8 Global Synthetic Biology Market, By Region
9 North America Synthetic Biology Market Analysis and Forecast (2020-2027)
10 EuropeSynthetic Biology Market Analysis and Forecast (2020-2027)
11 Asia Pacific Synthetic Biology Market Analysis and Forecast (2020-2027)
12 Latin America Synthetic Biology Market Analysis and Forecast (2020-2027)
13 Middle East Synthetic Biology Market Analysis and Forecast (2020-2027)
14 Competitive Analysis
15 Company Profiles
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Codexis Inc.
- Synthetic Genomics Inc
- Twist Bioscience
- Genscript Biotech Corporation
- Intrexon Corporation
- Amyris Inc.
- Ginkgo Bioworks
- Novozymes A/S
- Agilent Technologies Inc
- Merck Kgaa
